VXRT Stock Analysis

VXRT -  USA Stock  

USD 7.80  0.14  1.76%

The newest price gain of Vaxart may raise some interest from private investors as it is trading at a share price of 7.80 on 25,443,900 in trading volume. The company executives may have good odds in positioning the company resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.69. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Vaxart Inc partners.
Also, please take a look at World Market Map.

Search Stock Analysis 

The Vaxart stock analysis report makes it easy to digest most publicly released information about Vaxart and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. VXRT stock analysis module also helps to analyze the Vaxart price relationship with some important fundamental indicators such as market cap and management efficiency.

VXRT Stock Analysis Notes

About 34.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.46. Vaxart Inc next dividend is scheduled to be issued on the 9th of November 2012. The entity had a split on the 14th of February 2018. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people. For more information please call Wouter Latour at 650 550 3500 or visit http://vaxart.com.

Vaxart Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vaxart's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaxart Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vaxart Inc is way too risky over 90 days horizon
Vaxart Inc appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 1.65 M. Net Loss for the year was (46.93 M) with loss before overhead, payroll, taxes, and interest of (15.82 M).
Vaxart Inc currently holds about 157.31 M in cash with (37.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Latest headline from www.fool.com: Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today - Motley Fool

VXRT Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vaxart is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaxart Inc backward and forwards among themselves. Vaxart's institutional investor refers to the entity that pools money to purchase Vaxart's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
State Street CorpCommon Shares8.5 M51.3 M
Vanguard Group IncCommon Shares5.5 M33.1 M
Blackrock IncCommon Shares5.4 M32.8 M
Geode Capital Management LlcCommon Shares1.4 M8.7 M
Susquehanna International Group LlpPut Options1.4 M8.4 M
Susquehanna International Group LlpCommon Shares1.1 M6.7 M
Principal Financial Group IncCommon Shares797.1 K4.8 M
Susquehanna International Group LlpCall Options789.1 K4.8 M
Northern Trust CorpCommon Shares737.2 K4.5 M
Note, although Vaxart's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

VXRT Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxart's market, we take the total number of its shares issued and multiply it by Vaxart's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (22.2) % which means that it has lost $22.2 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (45.23) %, meaning that it created substantial loss on money invested by shareholders. Vaxart management efficiency ratios could be used to measure how well vaxart inc manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of June, Vaxart has the Risk Adjusted Performance of 0.0478, semi deviation of 6.44, and Coefficient Of Variation of 1645.28. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxart Inc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Vaxart Inc, which can be compared to its competition. Please validate Vaxart Inc market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Vaxart is priced more or less accurately, providing market reflects its prevalent price of 7.8 per share. Given that Vaxart Inc has jensen alpha of 0.5505, we advise you to double-check Vaxart Inc's current market performance to make sure the company can sustain itself at a future point.

Vaxart Inc Price Movement Analysis

The output start index for this execution was six with a total number of output elements of fifty-five. The Weighted Moving Average calculates a weight for each value in Vaxart price series with the more recent values given greater weights. View also all equity analysis or get more info about weighted moving average overlap studies indicator.

Vaxart Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaxart insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaxart's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaxart insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Floroiu Cezar Andrei 2 days ago via Macroaxis 
Acquisition by Floroiu Cezar Andrei of 250000 shares of Vaxart subject to Rule 16b-3
Yedid Robert A few days ago via Macroaxis 
Exercise or conversion by Yedid Robert A of 18240 shares of Vaxart subject to Rule 16b-3
Wouter Latour over a month ago via Macroaxis 
Exercise or conversion by Wouter Latour of 100000 shares of Vaxart subject to Rule 16b-3
Sean Tucker over a month ago via Macroaxis 
Exercise or conversion by Sean Tucker of 1006 shares of Vaxart subject to Rule 16b-3
Sean Tucker over three months ago via Macroaxis 
Exercise or conversion by Sean Tucker of 1006 shares of Vaxart subject to Rule 16b-3
Wouter Latour over three months ago via Macroaxis 
Exercise or conversion by Wouter Latour of 150000 shares of Vaxart subject to Rule 16b-3
Armistice Capital Llc over six months ago via Macroaxis 
Sale by Armistice Capital Llc of tradable shares of Vaxart
Wilson Karen J over six months ago via Macroaxis 
Acquisition by Wilson Karen J of 65700 shares of Vaxart subject to Rule 16b-3
Sean Tucker over six months ago via Macroaxis 
Exercise or conversion by Sean Tucker of 4026 shares of Vaxart subject to Rule 16b-3
Wouter Latour over six months ago via Macroaxis 
Exercise of in-the-money or at-the-money derivative position by Wouter Latour of 166667 shares of Vaxart
Floroiu Cezar Andrei over a year ago via Macroaxis 
Acquisition by Floroiu Cezar Andrei of 900000 shares of Vaxart subject to Rule 16b-3
Hudson Leslie over a year ago via Macroaxis 
Acquisition by Hudson Leslie of 8711 shares of Vaxart subject to Rule 16b-3

Vaxart Predictive Daily Indicators

Vaxart intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vaxart stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vaxart Forecast Models

Vaxart time-series forecasting models is one of many Vaxart's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vaxart's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Vaxart Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vaxart stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VXRT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Vaxart. By using and applying VXRT Stock analysis, traders can create a robust methodology for identifying VXRT entry and exit points for their positions.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vaxart to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Transformation Now


Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Module
Also, please take a look at World Market Map. Note that the Vaxart Inc information on this page should be used as a complementary analysis to other Vaxart's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Vaxart Stock analysis

When running Vaxart Inc price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
The market value of Vaxart Inc is measured differently than its book value, which is the value of VXRT that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine Vaxart value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.